Insulin NovoNordisk Levemir 100 E/ml FlexPen
Insulin NovoNordisk Levemir 100 E/ml FlexPen is a medicine authorised by Swissmedic under authorisation number 56371. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 November 2003 and the authorisation is limited until 31 March 2027. ATC code A10AE05 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 56371 |
|---|---|
| Name | Insulin NovoNordisk Levemir 100 E/ml FlexPen |
| Full name | Insulin NovoNordisk Levemir 100 E/ml FlexPen, Injektionslösung |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AE05 |
| First authorisation | 10 November 2003 |
| Authorisation validity | 31 March 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Insulin NovoNordisk Levemir 100 E/ml FlexPen, Injektionslösung | B | 30 April 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 5 x 3 | ml | A10AE05 | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Insulin NovoNordisk Levemir 100 E/ml FlexPen authorised in Switzerland?
Yes. Insulin NovoNordisk Levemir 100 E/ml FlexPen is authorised by Swissmedic under authorisation number 56371, data as of 01 September 2026. The authorisation is limited until 31 March 2027.
Which dispensing category does Insulin NovoNordisk Levemir 100 E/ml FlexPen have?
Insulin NovoNordisk Levemir 100 E/ml FlexPen is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Insulin NovoNordisk Levemir 100 E/ml FlexPen?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.